APOA1 and inflammatory bowel disease: An investigation in inflammatory bowel disease patients revealed significantly lower serum cholesterol, HDL-cholesterol, apoA-I, apoC-II, apoC-III bound to apoB, phospholipids, and phospholipids not bound to apoB levels, and apoA-I immunoreactivity compared to healthy controls [97].